Search

Search Constraints

You searched for: Author/Creator Groisberg, Roman

Search Results

2. Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials. Issue 1 (19th December 2017)

3. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

4. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

5. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

6. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

7. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

8. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

9. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)

10. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. Issue 2 (5th October 2020)